SCYNEXIS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCYNEXIS and other ETFs, options, and stocks.

About SCYX

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. 

CEO
David Angulo Gonzalez
CEODavid Angulo Gonzalez
Employees
28
Employees28
Headquarters
Jersey City, New Jersey
HeadquartersJersey City, New Jersey
Founded
1999
Founded1999
Employees
28
Employees28

SCYX Key Statistics

Market cap
39.76M
Market cap39.76M
Price-Earnings ratio
-2.20
Price-Earnings ratio-2.20
Dividend yield
—
Dividend yield—
Average volume
99.80K
Average volume99.80K
High today
$1.10
High today$1.10
Low today
$0.9405
Low today$0.9405
Open price
$1.05
Open price$1.05
Volume
103.50K
Volume103.50K
52 Week high
$3.07
52 Week high$3.07
52 Week low
$0.7284
52 Week low$0.7284
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.